BH3:FRA
PTC Therapeutics, Inc.
€55.00
arrow_downward
-0.61%(-0.34) 1 天
10月9日, GMT+2 22:00:00 · EUR
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 BH3 生成关键数据洞见…
开盘价
€55.00
最高价
€55.00
最低价
€55.00
市值
54.00亿
平均成交量
0.00
成交量
0.00
52 周最高价
€77.02
52 周最低价
€52.50
员工人数
991
开盘价
€55.00
最高价
€55.00
最低价
€55.00
市值
54.00亿
平均成交量
0.00
成交量
0.00
52 周最高价
€77.02
52 周最低价
€52.50
员工人数
991
新闻报道
来自网络来源和新闻合作伙伴
Investing.com Canada
·
1天前
Form 144 PTC THERAPEUTICS For: 10 October By Investing.com
Investing.com
·
2天前
PTC Therapeutics director Michael Schmertzler sells $158k in shares
Investing.com Canada
·
2天前
Form 4 PTC Therapeutics Inc For: 9 October By Investing.com
资料
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases.
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019. Wikipedia
PTC Therapeutics, Inc.简介